MEJLGAARD INVEST ApS: Financial statements 2022
CVR: 10042933
Source: annual report 2022, Danish Business Authority
01/05/2021 – 30/04/2022
MEJLGAARD INVEST ApS (CVR 10042933) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -48,031 and a net result of DKK -493,634 compared with DKK 3,708,378 the year before. Equity in the 2022 report amounted to DKK 16,282,859. The solvency ratio was 99.8%. The company had 1 employee in the financial year.
- Gross Profit
- DKK -48,031
- Profit/Loss
- DKK -493,634
- Equity
- DKK 16,282,859
- Total Assets
- DKK 16,311,859
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | -48K | -494K | 16.3M | 1 |
| 2021 | - | -46K | 3.7M | 16.9M | 1 |
| 2020 | - | -40K | 1.2M | 13.3M | 1 |
| 2019 | - | -48K | 1.7M | 12.2M | 1 |
| 2018 | - | -42K | 391K | 10.6M | 0 |
Official annual report
Keep an eye on MEJLGAARD INVEST ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
As of June 10, 2022, REDMARK, GODKENDT REVISIONSPARTNERSELSKAB has stepped down as auditor of MEJLGAARD INVEST ApS.
About MEJLGAARD INVEST ApS
MEJLGAARD INVEST ApS was a Danish company of the type Anpartsselskab based in Hellerup, founded in 1985. The company has been dissolved on 3 September 2024. The company was registered under the industry Virksomhedsrådgivning og anden rådgivning om driftsledelse. The company was previously named S.M.J. PHARMA AF 1/10 85 ApS. The company has 1 employee (2023). In 2023, the company reported a gross profit of DKK -35,584 and a net result of DKK 99,498 compared with DKK -493,634 the year before. Equity in the 2023 report amounted to DKK 16,267,957.
